ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CHRT Cohort Plc

1,070.00
-5.00 (-0.47%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cohort Plc LSE:CHRT London Ordinary Share GB00B0YD2B94 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -5.00 -0.47% 1,070.00 1,065.00 1,075.00 1,090.00 1,060.00 1,070.00 89,273 16:35:05
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Business Consulting Svcs,nec 202.53M 15.32M 0.3663 28.94 449.49M
Cohort Plc is listed in the Business Consulting Svcs sector of the London Stock Exchange with ticker CHRT. The last closing price for Cohort was 1,075p. Over the last year, Cohort shares have traded in a share price range of 520.00p to 1,110.00p.

Cohort currently has 41,813,011 shares in issue. The market capitalisation of Cohort is £449.49 million. Cohort has a price to earnings ratio (PE ratio) of 28.94.

Cohort Share Discussion Threads

Showing 1201 to 1223 of 1475 messages
Chat Pages: 59  58  57  56  55  54  53  52  51  50  49  48  Older
DateSubjectAuthorDiscuss
01/2/2023
16:56
Enjoyed the presentation thanks for organising it
norbert colon
03/1/2023
23:07
Tipped as a BUY in IC , thinks the political industrial complex is the new central bank.
wad collector
15/12/2022
09:44
It has key defence technology and its bound to win a lot more business in the new year
estienne
15/12/2022
07:59
For the six months to 31 October 2022, Cohort plc reported a strong performance: revenue was up 29%YoY to £77.5m; an operating profit (adj.) of £5.0m was achieved (H1 22: £1.7m); and EBITDA (adj.) was £7.1m. Order intake of £88.6m resulted in a record closing order book of £304.2m. The interim dividend is raised 10% to 4.25p/share.

Absorption of working capital meant that H1 net debt was £0.6m; however, Cohort reports that as of 9th December net funds were £7.6m. Added to H1 revenue, over £80m of orders deliverable in the second-half equates to 95% coverage of our revised full year revenue outlook of £165.0m.

A strong interim performance, in particular by MCL, supports an increase in our FY23 revenue outlook of 3%, to £165m, growth of 19.9%YoY; while our EBITDA (adj.) outlook remains at £22.0m (up 13.1%YoY).

We maintain our Fair Value of 650p/share.

edmonda
14/12/2022
12:14
Cohort plc posted Interims for the 6 months ended 31st October this morning which reported a much stronger first half for the Group with a record closing order book. Revenues were up 29% to £77.5m, adjusted operating profit was up significantly to £5.0m and adjusted EPS up to 10.12p (2021: 3.04p). The record closing order book reached £304.2m and the interim dividend was increased by 10% to 4.25p. Valuation is relatively attractive with forward PE at 11.6x, the balance sheet is solid. Share price has been drifting sideways or lower for nearly 3 years and lacks momentum. Ongoing solid business performance could act as a catalyst for some renewed share price appreciation, but there is no rush to buy. CHRT is a share to monitor for now...

...from WealthOracle

kalai1
14/12/2022
10:40
They were above 800p before COVID. The drop in price was purely because of that and its been there ever since
estienne
14/12/2022
10:31
Surprised no comemnts after very solid interims and c9-10% rise. These ought to be in 600p+ territory if they can maintain the momentum

GLA

petomi
27/9/2022
07:11
AGM update looks good: Cohort sees performance ahead of last year with order book now over £300m. Effective defence remains crucial; so no change to Equity Development forecasts and Fair Value of 650p/share

New research note out today along with audio audio summary. Free access here:

edmonda
25/8/2022
06:35
Pretty decent. Profited up and dividend up 10% ;-)
terminator101
12/8/2022
07:02
As per the title of this thread - Ukraine has prompted a global rethink on the need for defence. Cohort has a record £291m order and Equity Developement initiate coverage today with a Fair Value of 650p/share.

Read full note / hear summary below (free access):

edmonda
08/5/2022
11:22
Anyone on TECHINVEST, I am wanting to form a group of similar minded people to discuss its views etc and information.

Click my name and send a note.

matthew palmer
25/4/2022
22:24
Around 515

Seems ok for now. If it can keep well above 500 to month end, this might have x1 potential

vlad the impaler
25/4/2022
21:54
It might be if you got in early today!
wad collector
25/4/2022
08:38
In

Not so sure wisest day to be but is what it is

vlad the impaler
23/4/2022
14:34
Order set for 512 for this month (as of today) although above 500 start next month will do me
vlad the impaler
25/2/2022
23:34
Think these are worth a punt.
brut winky
23/2/2022
07:12
Contract win at last. Now we need Chess to deliver. Maybe antidrone warfare may come to the fore given current tensions
robertball
14/2/2022
18:14
personal marker at 473 mid - 1st visit since dec 2010 - Certainly should have bought then but sold a year ago. - Memo - Some of the quietest threads conceal some of the greatest investment opportunities.#

However timing is key.

pugugly
14/2/2022
17:51
...a bit dated, from last summer...

Cohort is a parent company of 6 innovative businesses providing services for British, Portuguese and international customers in the defence industry. Company’s ambition is to unite flourishing SMEs under one roof, where they can benefit from better financial oversight, management and exchange of knowledge and information. The Group provides surveillance, tracking, fire-control, communications, sonar, digital and other systems. The parent company aims to maintain growth prospects through widening market access, via acquisitions or organically, and a strong balance sheet.
Cohort has generated an Operating profit CAGR of 12.8%, and rising capex proving groups ambition to innovate and enhance its products and services. Cash flow has been fluctuating, mainly due to acquisition activities. Latest trading report presents the result of the company’s strategy over the past 5 years. Preliminary results show revenue growth of 9% yoy, with statutory profit before tax 29% above 2020 figures. Future growth of the Group is firmly supported by a 45% increase in order intake at £180.3m and Order book reaching £242.4m (32% above 2020). Better than expected cash performance and expectations of zero net debt on 30 April 2022 are in line with company’s values...from WealthOracleAM

km18
16/12/2021
12:18
Yes. I am a bit surprised. I though if selling at 480 (first loss is the best loss as they say) but price bounced up. Volume is low
robertball
16/12/2021
10:47
It seems to be recovering
estienne
14/12/2021
10:00
I agree shaker with you 438. We may see some mgt changes as Nick Prest as chair won't be too happy.

I will be holding and may add when I have had a chance to study properly

GLA

petomi
14/12/2021
09:46
Reads as though group board didn't stay close enough to Chess and Eid earlier. Long term this disappointing set of results will get fixed imo and I will add once we have seen the bottom
shaker44
Chat Pages: 59  58  57  56  55  54  53  52  51  50  49  48  Older

Your Recent History

Delayed Upgrade Clock